MNIMBS
Dhtml Menu Css by Vista-Buttons.com v5.7
 

Douglas M. Smith, PhD

Research Assistant Professor

Department of Internal Medicine

Michigan Nanotechnology Institute for Medicine and Biological Sciences

9346 MSRB III

1150 West Medical Center Drive, SPC 5648

734-647-0052

smitdoug@umich.edu

Dr. Smith earned his B.Sc. in Microbiology and Immunology at McGill University, Montreal, Quebec in 1979 and his Ph.D. degree in 1987 in Immunology at the University of Chicago, Chicago, IL. His dissertation work focused on the basic mechanisms for alloantigen recognition by T-cells as related to allograft rejection in animal transplant models.  He continued with a fellowship at the University of Chicago till 1991, when he was appointed to Chief Research Technologist in the Department of Surgery, University of Chicago. He was responsible for derivation and characterization of novel monoclonal antibodies for human transplant immunosuppressive therapy.  This work involved extensive interaction between both basic immunology and transplant surgery groups in a translational research program.  These studies culminated with the derivation and characterization of a potent immunosuppressive monoclonal antibody directed against a monomorphic region of human class I HLA molecules. 

He started his industrial career as a Research Scientist at Aastrom Biosciences, Inc., Ann Arbor, MI in 1996 where he was regularly promoted and ended his employment in May 2008 as a Principal Scientist.  He established and directed programs focusing on adoptive T-cell immunotherapy, dendritic cell vaccines for infectious diseases and cancer, and immunologic characterization of adult stem cells for human tissue repair.  These programs enabled development and clinical evaluation of a novel perfusion bioreactor system for production and genetic transduction of different cell types for emerging applications in human cell therapy. 

Current research as a member of the vaccine development team of MNIMBS is focused on development, characterization and application of nanoemulsion based adjuvants for intranasal induction of systemic and mucosal immunity. 

 

Spacer

© The Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS)® 2010
MNIMBS is a registered trademark of The Michigan Nanotechnology Institute for Medicine and Biological Sciences.
MNIMBS logo and graphic designed by Paul D. Trombley, website by Mellon & Associates, LLC
All other company, brand, and product names are or may be trademarks of their respective holders.